Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study
Ezra E.W. Cohen(University of California San Diego), Denis Soulières(Centre Hospitalier de l’Université de Montréal), Christophe Le Tourneau(Inserm), José Dinis(IPO Porto), Lisa Licitra(University of Milan), Myung‐Ju Ahn(Samsung Medical Center), Ainara Soria(Hospital Universitario Ramón y Cajal), Jean‐Pascal Machiels(Cliniques Universitaires Saint-Luc), Nicolas Mach(Hôpital Beau-Séjour), Ranee Mehra(Fox Chase Cancer Center), Barbara Burtness(Yale Cancer Center), Pingye Zhang(Merck & Co., Inc., Rahway, NJ, USA (United States)), Jonathan D. Cheng(Merck & Co., Inc., Rahway, NJ, USA (United States)), Ramona F. Swaby(Merck & Co., Inc., Rahway, NJ, USA (United States)), Kevin J. Harrington(Royal Marsden NHS Foundation Trust), Mirelis Acosta-Rivera, Douglas R. Adkins, Morteza Aghmesheh, Myung‐Ju Ahn(Samsung Medical Center), Mario Airoldi, Eduardas Aleknavičius, Yousuf Al-Farhat, Alain P. Algazi, Salah Almokadem, Anna Alyasova, Jessica R. Bauman, Marco Benasso, Alfonso Berrocal, Victoria Bray, Barbara Burtness(Yale Cancer Center), Francesco Caponigro, Ana Castro, Terrence P. Cescon, Kelvin Chan, Arvind Chaudhry, Bruno Chauffert, Ezra E.W. Cohen(University of California San Diego), Tibor Csőszi, Jan Paul de Boer, Jean‐Pierre Delord, Andreas Dietz, José Dinis(IPO Porto), Charlotte Dupuis, Laurence Digue, József Erfán, Yolanda Escobar Alvarez, Mererid Evans, Mary J. Fidler, Martin Förster, Signe Friesland, Apar Kishor Ganti, Lionnel Geoffrois, Clíona Grant, Viktor Gruenwald, Kevin J. Harrington(Royal Marsden NHS Foundation Trust), Thomas K. Hoffmann, Geza Horvai, Arturas Inčiūra, Raymond Woo-Jun Jang, Petra Jankowska, Antonio Jimeno, Mano Joseph, Alejandro Juárez Ramiro, Bogusława Karaszewska, Andrzej Kawecki, Ulrich Keilholz, Ulrich Keller, Sung‐Bae Kim, Judit Kocsis, Nuria Kotecki, Mark Kozloff, J. Lambea, László Landherr, Yuri Lantsukhay, Sergey Lazarev, Lip Way Lee, Christophe Le Tourneau(Inserm), Lisa Licitra(University of Milan), Igor Lifirenko, Nicolas Mach(Hôpital Beau-Séjour), Danko Martincic, О. В. Маторин, Margaret McGrath, Jean‐Pascal Machiels(Cliniques Universitaires Saint-Luc), Ranee Mehra(Fox Chase Cancer Center), Krzysztof Misiukiewicz, John C. Morris, Ф. Ф. Муфазалов, Jiaxin Niu, Devraj Srinivasan, Pedro Pérez Segura, Daniel Rauch, Maria Leonor Ribeiro, Cristina P. Rodriguez, Frédéric Rolland, Antonio Russo, Ágnes Ruzsa, Frederico Sanches, Sangwon Shin, Mikhail Shtiveland, Denis Soulières(Centre Hospitalier de l’Université de Montréal), Ainara Soria(Hospital Universitario Ramón y Cajal), Pol Specenier, Éva Szekanecz, Judit Szota, Carla M.L. van Herpen, Hector A. Velez-Cortes, William V. Walsh, Stefan Wilop, Ralph Winterhalder, Marek Z. Wojtukiewicz, Deborah Jean Lee Wong, Dan P. Zandberg
Cited by 1,686Open Access
Abstract
Related Papers
Toxicity and response criteria of the Eastern Cooperative Oncology Group
Martin M. Oken, Richard H. Creech, Douglass C. Tormey et al.|American Journal of Clinical Oncology|1982|11.6k